Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Michalaki

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 27, 2010
Mitomycin C and UFT/leucovorin as salvage treatment in patients with advanced colorectal cancerV Michalaki, S Gennatas, C Gennatas
Anticancer Research|July 18, 2008
Irinotecan plus capecitabine as first-line chemotherapy in advanced colorectal cancerC Gennatas, V Michalaki, S Gennatas, et al.
British Journal of Cancer|May 20, 2004
Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancerV Michalaki, K Syrigos, P Charles, et al.
Molecular and Cellular Biochemistry|February 24, 2005
Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancerV Michalaki, G Koutroulis, K Syrigos, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 8, 2009
Breast cancer in association with thyroid disordersV Michalaki, A Kondi-Pafiti, S Gennatas, et al.
Journal of Chemotherapy (Florence, Italy)|November 28, 2006
A prospective randomized study of irinotecan (CPT-11), leucovorin (LV) and 5-fluorouracil (5FU) versus leucovorin and 5-fluorouracil in patients with advanced colorectal carcinomaC Gennatas, G Papaxoinis, V Michalaki, et al.
Anticancer Research|March 14, 2007
A phase III randomized study comparing paclitaxel and cisplatin versus cyclophosphamide and cisplatin in patients with advanced ovarian cancerD Mouratidou, C Gennatas, V Michalaki, et al.
Clinical Nuclear Medicine|December 18, 2015
Comparison of 111In-[DTPA0]Octreotide Versus Non Carrier Added 177Lu- [DOTA0,Tyr3]-Octreotate Efficacy in Patients With GEP-NET Treated Intra-arterially for Liver MetastasesG S Limouris, V Poulantzas, N Trompoukis, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 27, 2010
Mitomycin C and UFT/leucovorin as salvage treatment in patients with advanced colorectal cancerV Michalaki, S Gennatas, C Gennatas
Anticancer Research|July 18, 2008
Irinotecan plus capecitabine as first-line chemotherapy in advanced colorectal cancerC Gennatas, V Michalaki, S Gennatas, et al.
British Journal of Cancer|May 20, 2004
Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancerV Michalaki, K Syrigos, P Charles, et al.
Molecular and Cellular Biochemistry|February 24, 2005
Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancerV Michalaki, G Koutroulis, K Syrigos, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 8, 2009
Breast cancer in association with thyroid disordersV Michalaki, A Kondi-Pafiti, S Gennatas, et al.
Journal of Chemotherapy (Florence, Italy)|November 28, 2006
A prospective randomized study of irinotecan (CPT-11), leucovorin (LV) and 5-fluorouracil (5FU) versus leucovorin and 5-fluorouracil in patients with advanced colorectal carcinomaC Gennatas, G Papaxoinis, V Michalaki, et al.
Anticancer Research|March 14, 2007
A phase III randomized study comparing paclitaxel and cisplatin versus cyclophosphamide and cisplatin in patients with advanced ovarian cancerD Mouratidou, C Gennatas, V Michalaki, et al.
Clinical Nuclear Medicine|December 18, 2015
Comparison of 111In-[DTPA0]Octreotide Versus Non Carrier Added 177Lu- [DOTA0,Tyr3]-Octreotate Efficacy in Patients With GEP-NET Treated Intra-arterially for Liver MetastasesG S Limouris, V Poulantzas, N Trompoukis, et al.
Pageof 1